Hedge funds are buying these two big tech stocks while selling two rivals
Investing.com - Wells Fargo has assumed coverage on Nutrien (NYSE:NTR) with an Equal Weight rating and a price target of $64.00, slightly lower than the previous target of $65.00. According to InvestingPro data, Nutrien currently trades at $58.94, with shares having delivered an impressive 35.7% return year-to-date.
The firm maintained its Equal Weight stance despite Nutrien’s strong third-quarter results, citing expectations for a challenging near-term environment for farmers due to a record North American harvest and weaker crop prices projected into 2026. The $64 price target represents 7.0x 2026 EV/EBITDA. InvestingPro analysis shows Nutrien currently trades at 8.06x EV/EBITDA (last twelve months) and offers a substantial 8% free cash flow yield.
Wells Fargo raised its fourth-quarter 2025 earnings per share estimate from $0.85 to $0.88, compared to the consensus estimate of $0.92, based on projected EBITDA of $1.308 billion, representing a 24.0% year-over-year increase.
For full-year 2025, the firm increased its EPS estimate from $4.50 to $4.60, reflecting a 32.5% year-over-year growth, in line with consensus estimates. This is based on projected EBITDA of $6.08 billion, up 13% year-over-year, with an EBITDA margin of 23.2% on sales growth of 4.6%.
Looking further ahead, Wells Fargo maintained its 2026 EPS estimate at $4.60 and its 2027 estimate at $4.65, representing year-over-year growth of 0% and 1.2% respectively, with 2026 EBITDA projected at $6.138 billion and 2027 EBITDA at $5.993 billion. With a current P/E ratio of 15.98 and a 3.7% dividend yield, Nutrien continues to reward shareholders through its dividend program, having raised dividends for 8 consecutive years.
In other recent news, Nutrien Ltd reported strong financial results for the third quarter of 2025, exceeding Wall Street expectations. The company achieved an earnings per share of $0.97, surpassing the forecasted $0.94. Additionally, Nutrien reported revenues of $6.01 billion, which also exceeded the anticipated $5.77 billion. These results indicate a positive performance and reflect investor confidence. The company’s financial achievements are noteworthy as they highlight Nutrien’s ability to outperform market predictions. This development comes amid various market activities and analyst reviews. Investors and analysts alike are closely monitoring Nutrien’s performance and future prospects. These recent developments provide valuable insights into the company’s current standing in the industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.